Oscar Health (OSCR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Voting matters and shareholder proposals
Election of eight director nominees to serve until the 2027 Annual Meeting, with all nominees recommended by the board.
Advisory vote on executive compensation (Say-on-Pay) is up for approval.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026 is proposed.
Additional business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Eight director nominees are presented for election, including Mark T. Bertolini, William J. Gassen III, Joshua Kushner, Laura Lang, David Alexander Plouffe, Siddhartha Sankaran, Mario Schlosser, and Vanessa Ames Wittman.
Executive compensation and say-on-pay
Shareholders are asked to approve, on an advisory basis, the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Oscar Health
- Proxy covers director elections, say-on-pay, auditor ratification, and robust governance practices.OSCR
Proxy filing23 Apr 2026 - Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Record 2025 revenue and membership, but higher costs led to a net loss; 2026 targets profitability.OSCR
Q4 202510 Feb 2026 - AI, personalization, and expanded financial tools are key to driving real healthcare consumerism.OSCR
7th Annual Healthcare Symposium3 Feb 2026 - Q2 revenue up 46%, net income $56.2M, membership up 63%, and full-year guidance raised.OSCR
Q2 20242 Feb 2026 - Aims for 20% revenue CAGR and 5% margin by 2027, leveraging ACA, ICHRA, and technology.OSCR
Investor Day 20241 Feb 2026 - Reaffirmed guidance, robust growth outlook, and disciplined strategy set the stage for 2025.OSCR
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Strong growth, disciplined expansion, and AI-driven efficiency position for long-term outperformance.OSCR
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - SEP-driven growth and disciplined pricing set up strong 2025 performance and long-term margin gains.OSCR
The Baird 2024 Global Healthcare Conference20 Jan 2026